shortagewatch

Home / Cardiovascular system / Captopril

ATC C09AA01 · Ace Inhibitors, Plain

Captopril shortage

As of 2 Nov 2026, Captopril has a reported shortage in 1 of the 15 countries we track (Canada), covering 5 products from 2 companies.

Countries1/15
Products5packs or presentations
Companies21 listed
Short since24 Sep 20242.1 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada5 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage

Timeline

Canada
202520262027APO-CAPTO TAB 25MG (100 BTL)APO-CAPTO TAB 25MG (100 BTL)TEVA-CAPTOPRIL (100)TEVA-CAPTOPRIL (100)APO-CAPTO TAB 50MG (100 BTL)APO-CAPTO TAB 50MG (100 BTL)APO-CAPTO TAB 12.5MG (100 BTL)APO-CAPTO TAB 12.5MG (100 BTL)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Apotex4Teva1 TEVA

Listed: Teva TEVA · NYSE / TASE

Compared with similar medicines

ATC group C09AA · Ace Inhibitors, Plain
Ramipril9/15Enalapril8/15Lisinopril5/15Perindopril5/15Trandolapril4/15Quinapril2/15Captopril1/15Cilazapril1/15Fosinopril1/15

Affected products

CountryProductCompanySinceExpected backReason
CAAPO-CAPTO TAB 25MG (100 BTL)APOTEX INC24 Sep 2024not givenManufacturing problem
Disruption of the manufacture of the drug
CATEVA-CAPTOPRIL (100)TEVA CANADA LIMITED2 Jul 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-CAPTO TAB 50MG (100 BTL)APOTEX INC4 Sep 2025not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-CAPTO TAB 12.5MG (100 BTL)APOTEX INC13 Oct 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-CAPTO TAB 100MG (100 BTL) anticipatedAPOTEX INC1 Sep 2028not givenManufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.